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Urinary stress incontinence
Benefits of using tension›free vaginal tape remain unproved
New minimal access surgical sling proceduressuch as the tension›free vaginal tape pro›cedure are now being used to treat urinary
stress incontinence in women. These procedures use
minimal tension—urethral support is perhaps achieved
from a tissue reaction to the tape, which produces a col›
lagen scar along the length of the tape and increases
support of the bladder when the rectus muscle contracts.
The tension›free vaginal tape procedure is often carried
out under regional or local anaesthesia. Many women
would undoubtedly welcome the choice of a less invasive
procedure than open retropubic colposuspension—as
long as the minimal procedure cures urinary inconti›
nence and does not result in major complications.
What does the currently available evidence say? Two
recent systematic reviews concluded that, although the
minimal access surgical sling procedures (and particu›
larly tension›free vaginal tape) may be promising, the
quality of the evidence available so far is not
conclusive.1 2 So far almost all the evidence has come
from case series. So the six month results for the first
multicentre randomised trial of tension›free vaginal
tape have been eagerly awaited,3 since only preliminary
results could be included in these systematic reviews.
Ward et al concluded that in their trial tension›free
vaginal tape was as effective as colposuspension in
treating stress incontinence. Several aspects of the trial,
as well as results from other studies of tension›free
vaginal tape, indicate that this claim may still be some›
what premature. In the trial, the authors prespecified
that a difference of 10% in cure rates between tension›
free vaginal tape and colposuspension would be
clinically important, but unfortunately they were
unable to recruit the required number of 394 patients
overall. Ultimately 344 women were randomised, and
only 287 completed the urodynamic investigations at
six months—156/175 (89%) after tension›free vaginal
tape and 131/169 (78%) after colposuspension. Ward
et al analysed most of their data on an intention to treat
basis, making the assumption that all missing patients
were treatment failures. This assumption is question›
able, however, and it would have been better also to
reanalyse assuming missing patients were treatment
successes and then attempt to explain any differences
between the sets of results.4 Unfortunately, a more cor›
rect interpretation (taking into consideration the
underpowered study and missing results) is that
tension›free vaginal tape may be better, worse, or the
same as colposuspension in this study.
Of greater concern, however, may be the biases
inherent in this study that seem to favour tension›free
vaginal tape. A large number of women who agreed to
join the trial seem to have withdrawn when placed in
the colposuspension group. Given that the study was
performed in the NHS and that tension›free vaginal
tape may have been readily available for trials only, it
may well be that patients were willing to continue in
the trial only if they were allotted to the group treated
with the less invasive approach. The report mentions
that the women who withdrew from the colposuspen›
sion group before surgery had less severe inconti›
nence. This reinforces the importance of closer
analysis of these women in interpreting the results
obtained, ideally in a true intention to treat analysis,
which requires testing of several assumptions.
Irrespective of these statistical and methodological
concerns, women treated with vaginal tape had shorter
operating times and reduced hospital stays than
women treated with open colposuspension, as would
be expected from a less invasive technique. They were
also able to return to work and normal activities more
rapidly. What remains to be addressed, even if the
operations are of equal short term benefit for inconti›
nence, is the issue of long term cure rates. This will
require further follow up of patents in both groups.
Women will also need to base their decisions on the
possibility of complications. The trial showed more
intraoperative complications, such as perforation of
the bladder, in the vaginal tape group. Postoperative
complications, such as infections, were more prevalent
in the colposuspension group.
Although this study begins to add evidence from
randomised controlled trials, at best we can conclude
only that we need further studies with adequate power
and long term follow up, whose outcomes are analysed
more stringently. The study by Ward et al also shows
that, even when resources can be found to start a
randomised controlled trial, many factors coincide to
make surgical research problematic. It is often difficult to
recruit sufficient patients to produce a robust result.
Especially in surgery, authors of underpowered trials
tend to make unsupported recommendations for
changes in practice.5 The often unknown motivations of
participants who withdraw from trials once they are
aware of their treatment allocation and the multiple
reasons for becoming lost to later follow up make inten›
tion to treat analyses more complex. For surgical
randomised controlled trials, issues related to the learn›
ing curve and differences in performance between
surgeons complicate analysis of results even further.6 7
We must, however, find ways to optimise the ability
of randomised controlled trials to answer the questions
that they were designed to answer. Funders need to be
prepared to fund randomised controlled trials on the
basis of realistic recruitment rates, or they may need to
provide “top up” or contingency funding so that trials
do not remain underpowered. Trialists should also
have access to specialised statisticians and methodolo›
gists who have the skills to model scenarios,
particularly for inputing missing data, such as losses to
follow up. The alternative is that we revert to reliance
on observations of current practices, where variation in
practice might be seen as a large but poorly controlled
experiment,8 to attempt to make informed choices
between treatments. The difficulties experienced with
the tension›free vaginal tape trial mean that women
needing to choose between minimal access and
conventional surgery still do not have enough evidence
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to make this decision, even though the difficulties were
probably surmountable.
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Your career: planning for the unexpected
Come to the BMJ Careers Fair and learn how to think about an unpredictable future
Are you somebody who plans ahead in life? Doyou have an idea of what you might be doing in10 years’ time? The training and work of
doctors is increasingly controlled. In Britain, for
example, specialist training is defined, general training is
being defined, and lifelong appraisal and revalidation
are being introduced. Everybody will need to have a per›
sonal development plan. Doctors might therefore feel
that their working life is being planned for them, but
these innovations come at a time when the future is
highly uncertain. Will the NHS still exist in 10 years’
time? What changes will the new genetics and
information technology bring? Will Britain be part of
the United States of Europe by 2020? What will it be like
to practise in a world where many patients with chronic
disease are better informed than their doctors? Might
another war break out? Might you develop a serious ill›
ness? People who want to think ahead need to recognise
that the world predictably changes in unpredictable
ways. But how can you think about the unpredictable
when that seems impossible? Those who would like to
learn one approach should read the article by Philip
Hadridge and Rhona MacDonald in BMJ Career Focus,
join a web vote, and come to the BMJ Careers Fair.1
Successful organisations have always thought about
the future, but they learnt years ago that the future was
unpredictable and that simply projecting trends
forwards led to false conclusions. Planners therefore
developed “scenario planning,” where instead of
predicting one future you imagine several plausible but
different futures. One way to do this is by identifying
drivers of change—such as new technology—and imag›
ining where these might lead. You then examine your
current plans in the light of these possible futures.
Plans that will work equally well in several of the worlds
are more likely to succeed. You can also reflect on what
the imagined worlds have in common and plan
accordingly.
The NHS has engaged in scenario planning, imag›
ining one world where people ceased to trust
institutions such as the NHS and another world where
people felt so overwhelmed by information that they
needed organisations they could trust.2 The BMJ has
used scenario planning to think about the future of
medical publishing. In one scenario research is made
available through large databases rather than journals.
A second scenario describes a world of global,
electronic conversation where publication, either
paper or electronic, is not important. In a third
scenario publishing is controlled largely by huge global
organisations—drug companies, technology compa›
nies, retailers, or bodies such as the World Bank.
Although it is routine for companies to plan for an
unpredictable future, it is rare for individuals. How many
doctors think about working in a future that might be
very different from now? Not many probably, although
the health service in 10 years’ time is highly likely to be
very different from now. The problem is to know how it
will be different. How many doctors think about a future
in which they might develop a chronic illness, suffer a
serious adverse event, or fall in love with somebody from
far away? Again, these things happen commonly but
unpredictably. That is why Philip Hadridge, Rhona Mac›
Donald, and others from BMJ Careers have used the
ideas behind scenario planning to help doctors plan for
an unpredictable future.1 Why not join in?
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